Therefore, patient participation and engagement in the selection of testosterone formulation is likely to promote adherence (57). Thus, drugs that are easier to administer and are relatively inexpensive result in greater compliance, particularly among patients who require lifelong therapy (54, 55), such as men with organic hypogonadism. Four participants reported small, painless nodules that resolved within 2 days, while 2 participants developed urticaria at the injection site within a few hours that persisted for up to 3 days. DirectMeds has built a legitimate, well-reviewed telehealth operation that makes prescribed NAD+ therapy accessible, well-structured, and hassle-free. Committing to at least a two-month trial before evaluating whether NAD+ therapy is right for you gives the treatment enough time to demonstrate its potential. Think of NAD+ injections as a performance multiplier on top of good habits—not a replacement for them. Stick to the five-times-per-week protocol your provider recommends, especially during the first two to three months when you're building up your baseline levels. Like other steroid hormones, testosterone is derived from cholesterol (Figure 1). However, the concentrations of testosterone required for binding the receptor are far above even total circulating concentrations of testosterone in adult males (which range between 10 and 35 nM). Greatly differing amounts of testosterone prenatally, at puberty, and throughout life account for a share of biological differences between males and females. Androgen receptors occur in many different vertebrate body system tissues, and both males and females respond similarly to similar levels. Immunofluorescence assays exhibit considerable variability in quantifying testosterone concentrations in blood samples due to the cross-reaction of structurally similar steroids, leading to overestimating the results. In measurements of testosterone in blood samples, different assay techniques can yield different results. 5α-Reductase is highly expressed in the male reproductive organs (including the prostate gland, seminal vesicles, and epididymides), skin, hair follicles, and brain and aromatase is highly expressed in adipose tissue, bone, and the brain. Two of the immediate metabolites of testosterone, 5α-DHT and estradiol, are biologically important and can be formed both in the liver and in extrahepatic tissues. Certain cytochrome P450 enzymes such as CYP2C9 and CYP2C19 can also oxidize testosterone at the C17 position to form androstenedione. In the mid-1950s, the longer-acting testosterone esters testosterone enanthate and testosterone cypionate were introduced. Unlike testosterone, AAS that are 17α-alkylated, like metandienone and stanozolol, are orally active. Prominent examples include nandrolone (19-nortestosterone), metandienone (17α-methyl-δ1-testosterone), and stanozolol (a 17α-alkylated derivative of DHT). This is known as hormone replacement therapy (HRT) or testosterone replacement therapy (TRT), which maintains serum testosterone levels in the normal range. In males, these are usual late pubertal effects, and occur in women after prolonged periods of heightened levels of free testosterone in the blood. Testosterone injection may cause a decrease in the number of sperm (male reproductive cells) produced, especially if it is used at high doses.Talk to your doctor about the risks of using this medication if you are a man and would like to have children. Testosterone injection may control your symptoms but will not cure your condition.Your doctor may adjust your dose of testosterone depending on the amount of testosterone in your blood during your treatment and your reaction to the medication. In contrast to these high doses, there is little support for the notion that testosterone is a critical hormone for sexual desire and function in women under normal physiological circumstances. Because of a lack data to support its efficacy and safety, the Endocrine Society recommends against the routine use of testosterone in women to treat low androgen levels due to hypopituitarism, adrenal insufficiency, surgical removal of the ovaries, high-dose corticosteroid therapy, or other causes. To take advantage of its virilizing effects, testosterone, often shortened to T, is administered to transgender men and other transmasculine individuals as part of masculinizing hormone therapy, titrated to clinical effect with a "target level" of the average male's testosterone level. Since the blood flow at the site of drug administration influences the pharmacokinetics of the administered drug, SC injections display more stable vascular absorption patterns compared to IM injection. The viability of using SC route for sex steroid administration was also shown in an elegant pharmacokinetic study in which nandrolone decanoate was administered to healthy male volunteers (30). In addition, testosterone therapy is used for gender-affirming (hormone) therapy for transgender men to induce masculinization (and suppress endogenous estradiol concentrations in patients with intact ovaries) (2). Testosterone is the main male sex hormone and is essential for the development and maintenance of male secondary sexual characteristics. Recently, subcutaneous (SC) administration of testosterone esters has gained popularity, as self-administration is easier with this route.
